CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
05/31/2025 | 02/28/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 22.50% | -34.13% | |||
Depreciation & Amortization | -380.00% | 25.00% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 26.56% | 7.98% | |||
Operating Income | -26.56% | -7.98% | |||
Income Before Tax | -25.18% | 0.21% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -25.18% | 0.21% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -25.18% | 0.21% | |||
EBIT | -26.56% | -7.98% | |||
EBITDA | -26.61% | -7.97% | |||
EPS Basic | -21.43% | 0.00% | |||
Normalized Basic EPS | -15.38% | -4.00% | |||
EPS Diluted | -83.33% | 0.00% | |||
Normalized Diluted EPS | -15.38% | -4.00% | |||
Average Basic Shares Outstanding | 0.90% | 0.56% | |||
Average Diluted Shares Outstanding | 0.90% | 0.56% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |